Notice Number: NOT-GM-18-013

Key Dates
Release Date: December 21, 2017

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to clarify that the eligibility of Program Directors/Principal Investigators (PDs/PIs) for PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)" is limited to Early Stage Investigators (ESIs). The MIRA ESI Funding Opportunity Announcement (FOA) provides support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. Accordingly, eligibility is limited to ESIs. While this is clearly stated in several sections of the FOA, it is not explicitly stated in Part 2. Section III. Eligibility Information as in previous FOAs for this program.

Part 2. Section III. I. Eligible Applicants
Eligible Individuals (Program Director/Principal Investigator)
The following paragraph has been added to this section to clarify that eligibility is limited to ESIs.

This FOA targets investigators who are beginning their independent research careers. Applications will be accepted from NIH defined Early Stage Investigators. Note that Early Stage Investigator status can be extended beyond the normal 10-year window after completion of the terminal research degree or medical residency for certain life or career events, as described in NOT-OD-09-034 and on the NIH website. Eligibility to receive the award is determined at the time of award. Applicants who receive R01, SC1, DP1, DP2, or any other type of disqualifying award prior to issuance of the MIRA, are not eligible to receive the award. Applications from investigators who are not eligible to receive the award will be administratively withdrawn without review.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Kristine Willis, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-0943
Email: [email protected]